Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Biofil Chemicals & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biofil Chemicals & Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioForce Nanosciences Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioForce Nanosciences Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biofrontera AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biofrontera AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioGaia AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioGaia AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biogen Idec Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biogen Idec Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

U.S. Stem Cell, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

U.S. Stem Cell, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioInvent International AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioInvent International AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biolin Scientific AB (publ). Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biolin Scientific AB (publ). Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioLineRx, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioLineRx, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioMarin Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioMarin Pharmaceutical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioMimetic Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioMimetic Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biomm Sa Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biomm Sa Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biomoda Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biomoda Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BiondVax Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BiondVax Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioneer Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioneer Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioniche Life Sciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioniche Life Sciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bionomics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bionomics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bionovo, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bionovo, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biopath Holdings, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biopath Holdings, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biophausia AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biophausia AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioponic Phytoceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioponic Phytoceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioPorto A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioPorto A/S Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 61 pages

Medibio Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medibio Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BIOQUAL, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BIOQUAL, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioQuanta S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioQuanta S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioSante Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioSante Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioScience Brands Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioScience Brands Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biosearch SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosearch SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biosensor Applications Sweden AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosensor Applications Sweden AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biosino Bio-Technology and Science Incorporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosino Bio-Technology and Science Incorporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioSpecifics Technologies Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioSpecifics Technologies Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biostar Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biostar Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biostem US Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biostem US Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biota Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biota Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotage AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotage AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotec Pharmacon ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotec Pharmacon ASA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotech Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotech Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotest AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotest AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotie Therapies Oyj Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotie Therapies Oyj Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioTime, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioTime, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BIOTON S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BIOTON S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotoxtech Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotoxtech Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biotron Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotron Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biovest International Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biovest International Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Biovet JSC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biovet JSC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BioWest Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioWest Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioxel Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioxel Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bliss Gvs Pharma Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bliss Gvs Pharma Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BMP Sunstone Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BMP Sunstone Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bohai Pharmaceuticals Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bohai Pharmaceuticals Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1